Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Hydromorphone
Strength: 8,00 mg
Dosage form: comprimido de liberación prolongada
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 14 Oct 2015
Registration: 79784
Marketing authorisation holder: Aristo Pharma Gmbh
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Estupefacientes

Edunix 2,6 MG Capsulas Duras EfgHydromorphone · 2,6 mg · cápsula duraSpain

Edunix 2,6 MG/ML Solucion OralHydromorphone · 2,6 mg/ml · solución oralSpain

Edunix 32 MG Comprimidos de Liberacion ProlongadaHydromorphone · 32,00 mg · comprimido de liberación prolongadaSpain

Edunix 4 MG Comprimidos de Liberacion ProlongadaHydromorphone · 4,00 mg · comprimido de liberación prolongadaSpain

JURNISTA 16 mg COMPRIMIDOS DE LIBERACION PROLONGADAHydromorphone · 16,35 mg · comprimido de liberación prolongadaSpainWithdrawn

JURNISTA 32 mg COMPRIMIDOS DE LIBERACION PROLONGADAHydromorphone · 32 mg · comprimido de liberación prolongadaSpainWithdrawn

JURNISTA 4 mg COMPRIMIDOS DE LIBERACION PROLONGADAHydromorphone · 4,36 mg · comprimido de liberación prolongadaSpainWithdrawn

JURNISTA 8 mg COMPRIMIDOS DE LIBERACION PROLONGADAHydromorphone · 8,72 mg · comprimido de liberación prolongadaSpainWithdrawn